If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Myeloid Leukemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Busulfan Medicine & Life Sciences
Leukocyte Elastase Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

1 Citation (Scopus)
Homologous Transplantation
Graft vs Host Disease
Neoplasms
Stem Cell Transplantation
Lymphoma
1 Citation (Scopus)

A novel T-cell engaging Bi-specific antibody targeting the leukemia antigen PR1/HLA-A2

Herrmann, A. C., Im, J. S., Pareek, S., Ruiz-Vasquez, W., Lu, S., Sergeeva, A., Mehrens, J., He, H., Al-Atrash, G., Sukhumalchandra, P., St John, L., Dwyer, K. C., Zha, D. & Molldrem, J. J., Jan 1 2019, In : Frontiers in immunology. 10, JAN, 3153.

Research output: Contribution to journalArticle

Open Access
HLA-A2 Antigen
Leukemia
T-Lymphocytes
Antibodies
Acute Myeloid Leukemia

Fucosylation enhances the efficacy of adoptively transferred antigen-specific cytotoxic T lymphocytes

Al-Atrash, G., Qiao, N., Zhang, M., Zope, M., Perakis, A. A., Sukhumalchandra, P., Philips, A. V., Garber, H. R., Kerros, C., St John, L. S., Khouri, M. R., Khong, H., Dwyer, K. C., Miller, L. P., Wolpe, S., Overwijk, W., Molldrem, J. J., Ma, Q., Shpall, E. & Mittendorf, E. A., Apr 15 2019, In : Clinical Cancer Research. 25, 8, p. 2610-2620 11 p.

Research output: Contribution to journalArticle

Cytotoxic T-Lymphocytes
Antigens
Fucosyltransferases
Bone Marrow
Breast Neoplasms
Open Access
T-Lymphocyte Subsets
Acute Myeloid Leukemia
Ligands
T-Lymphocytes
Bone Marrow
20 Citations (Scopus)

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Molina, J. R., Sun, Y., Protopopova, M., Gera, S., Bandi, M., Bristow, C., McAfoos, T., Morlacchi, P., Ackroyd, J., Agip, A. N. A., Al-Atrash, G., Asara, J., Bardenhagen, J., Carrillo, C. C., Carroll, C., Chang, E., Ciurea, S. O., Cross, J. B., Czako, B., Deem, A. & 46 othersDaver, N., de Groot, J. F., Dong, J. W., Feng, N., Gao, G., Gay, J., Do, M. G., Greer, J., Giuliani, V., Han, J., Han, L., Henry, V. K., Hirst, J., Huang, S., Jiang, Y., Kang, Z., Khor, T., Konoplev, S. N., Lin, Y. H., Liu, G., Lodi, A., Lofton, T., Ma, H., Mahendra, M., Matre, P., Mullinax, R., Peoples, M., Petrocchi, A., Rodriguez-Canale, J., Serreli, R., Shi, T., Smith, M., Tabe, Y., Theroff, J., Tiziani, S., Xu, Q., Zhang, Q., Muller, F., DePinho, R. A., Toniatti, C., Draetta, G., Heffernan, T. P., Konopleva, M., Jones, P., Di Francesco, M. E. & Marszalek, J. R., Jul 1 2018, In : Nature medicine. 24, 7, p. 1036-1046 11 p.

Research output: Contribution to journalArticle

Oxidative Phosphorylation
Tumors
Acute Myeloid Leukemia
Brain Neoplasms
Brain